FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000MC1YST1

Market Closed - Börse Stuttgart 20:51:52 10/05/2024 BST
0.59 EUR 0.00% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
Current month-11.94%
1 month-25.32%
Date Price Change Volume
10/05/24 0.59 0.00% 0
09/05/24 0.59 +3.51% 0
08/05/24 0.57 -5.00% 0
07/05/24 0.6 +11.11% 0
06/05/24 0.54 -5.26% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 08:51 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MC1YST
ISINDE000MC1YST1
Date issued 29/05/2019
Strike 264.7 $
Maturity Unlimited
Parity 104.61 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 23.34
Lowest since issue 0.17
Spread 0.01
Spread %1.67%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus